Noninvasive Ultrasound Assessment of Detrusor Dysfunction

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2023 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-04-20

Study Completion Date

2028-12-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to test a new ultrasound method called Quantitative Ultrasound Bladder Vibrometry to detect abnormal bladder function.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder

NCT04190641

Cystoscope Bladder Cancer Lower Urinary Tract Symptoms

COMPLETED NA

Evaluation of Performance and Safety of Ambu® aScope™ 4 Cysto and aView™ Urologia for Flexible Cystoscopy

NCT04192474

Cystoscope Lower Urinary Tract Symptoms Bladder Disease

COMPLETED NA

Assessment of the Uro-C Cystoscope for Use in Diagnostic Cystoscopy Procedures

NCT03331705

Bladder Tumor

UNKNOWN

Correlations of 3D Urethral and Paraurethral Sonographic Findings With Urodynamic Studies, Lower Urinary Tract Symptoms & Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms.

NCT01884753

Lower Urinary Tract Dysfunction Overactive Bladder Syndrome

COMPLETED

The Urinary Microbiome in Patients Receiving Intradetrusor Botox Injections

NCT04479709

Overactive Bladder

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to evaluate the effectiveness of quantitative ultrasound bladder vibrometry (QUBV) as a noninvasive tool for detrusor overactivity assessment and for benign prostatic hyperplasia (BPH) treatment selection. Participants in this study will have a QUBV ultrasound performed at the same time as a urodynamic study that had been ordered as part of their regular clinical care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bladder Dysfunction Overactive Bladder BPH With Urinary Obstruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aim1:

Age \>18 scheduled to undergo UDS for their clinical care for one of the included diagnoses.

-Aim2: Inclusions: Age \>45 scheduled to undergo selective photovaporization of the prostate.

Exclusion Criteria

* Aim1:Obesity (BMI \>35kg/m2), known neurologic disease impacting bladder function (e.g. spinal cord injury, multiple sclerosis, Parkinson's, prior cerebrovascular accident), previous pelvic radiation therapy, previous radical pelvic surgery (such as for uterine or colorectal cancer), prior bladder surgery (including prostate resection), and pregnant or breast-feeding women.
* Aim2:Obesity (BMI \>35kg/m2), known neurologic disease impacting bladder function (e.g. spinal cord injury, multiple sclerosis, Parkinson's, prior cerebrovascular accident), previous pelvic radiation therapy, previous radical pelvic surgery (such as colorectal cancer).

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No